Company Filing History:
3 out of 69 
2 out of 49 
1 out of 9 Years Active: 2013-2020
Title: Innovations of Lin Mei in Neurotransmission Disorders
Introduction
Lin Mei is a prominent inventor based in Evans, Georgia, known for his significant contributions to the field of neuroscience. He holds a total of six patents, focusing primarily on the detection and treatment of neurotransmission disorders. His work has the potential to impact the lives of individuals suffering from various neurological conditions.
Latest Patents
One of Lin Mei's latest patents addresses the detection and treatment of LRP4-associated neurotransmission disorders. This invention includes methods for identifying neurotransmission or developmental disorders, such as myasthenia gravis, which may be seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle-specific tyrosine kinase (MuSK). The method involves detecting autoantibodies that bind to LRP4 or its epitopes. Additionally, it outlines treatment methods for individuals suffering from these disorders, which include detecting autoantibodies in bodily fluids and administering effective amounts of immunosuppressants or other therapeutic modalities. The patent also encompasses antibodies that bind to autoantibodies to LRP4 and kits designed for the detection of these disorders.
Career Highlights
Lin Mei has worked with notable institutions such as the Augusta University Research Institute and the Medical College of Georgia Research Institute. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research on neurotransmission disorders.
Collaborations
Some of Lin Mei's notable coworkers include Wen-Cheng Xiong and Bin Zhang. Their collaborative efforts have contributed to the advancement of research in the detection and treatment of neurological disorders.
Conclusion
Lin Mei's innovative work in the field of neurotransmission disorders showcases his dedication to improving medical science and patient care. His patents reflect a commitment to addressing complex neurological challenges, making a significant impact in the healthcare industry.